Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Algernon Pharmaceuticals is a company that is doing two impo
View:
Post by stockpatrol on Feb 07, 2023 4:44pm

Algernon Pharmaceuticals is a company that is doing two impo

Algernon Pharmaceuticals is a company that is doing two important studies right now. One is a study to see if a drug called DMT is safe and works to treat stroke. The other study is to see if a drug called Ifenprodil works to treat chronic cough. They expect to get results from the first study in the third quarter of 2023 and start the second study in the same quarter. If the studies are successful, it could mean good things for the company and the treatments. Algernon Pharmaceuticals is currently trading at a low price compared to other similar companies.
 
https://www.reddit.com/r/PharmaStock/comments/10vixiu/algernon_pharmaceuticals_agnc_agnpf/
Be the first to comment on this post
Algernon Pharmaceuticals Inc.